Advertisement

Topics

Global IntraUterine Contraceptive Devices Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024 [Report Updated: 01032017] Prices from USD $4200

03:02 EST 16 Dec 2017 | BioPortfolio Reports

The Market of Global IntraUterine Contraceptive Devices Market is accounted to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016,it is growing at a CAGR of 3.5% in the forecast period 2017 to 2024.


The major factors driving the market for IntraUterine Contraceptive Devices IUCD, such as growing awareness of contraceptive, increased rate of unplanned pregnancies, rising number of initiatives undertaken by the private firms, technological advancements and favourable insurance for IUCD's.


The key market players for Global IntraUterine Contraceptive Devices Market are listed below:


Teva Pharmaceuticals Industries Ltd.,

Mona Lisa N.V.

DKT International,

Egemen International,

Melbea AG,

Ocon Medical Ltd.,

Pregna International Limited,

Medical Engineering Corporation SA

, SMB Corporation

Meril Life Sciences Pvt. Ltd.,

Medu Scientific Ltd,

China RH Contraceptives Co., Ltd,

Sanghai Jolly Medical Education Co., Ltd,

Bernstein Leibhard LLP,

ZheijangDaji Medical Instruments, Ltd.,

Nimble International,

AME Line,

Technico,

Cepeo,

Contraceptivos,

InjeflexInd

Com Ltda,

Bersil, Amed.


The market is further segmented into:

Product Type

End User

Geography


The Global IntraUterine Contraceptive Devices Market is segmented on the basis of product type, end user, and geography.

The global intrauterine contraceptive devices market is segmented into 2 product types, namely copper IUCD and hormonal IUCD.

On the basis of end users the market is segmented into hospitals, gynaecology clinics, and community healthcare. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.



Based on geography, the Global IntraUterine Contraceptive Devices market is segmented into 11 geographical regions, such as,

North America,

South America,

Europe,

APAC,

MEA




Covered in this report

The report covers the present scenario and the growth prospects of the Global IntraUterine Contraceptive Devices market for 20172021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration UCC and video conferencing, secondary resources and doing indepth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Original Article: Global IntraUterine Contraceptive Devices Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024 [Report Updated: 01032017] Prices from USD $4200

NEXT ARTICLE

More From BioPortfolio on "Global IntraUterine Contraceptive Devices Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024 [Report Updated: 01032017] Prices from USD $4200"

Quick Search
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Obstetrics and gynaecology
Fertility Menopause Obstetrics & Gynaecology Osteoporosis Women's Health Obstetrics and gynaecology comprises the care of the pregnant woman, her unborn child and the management of diseases specific to women. Most consultant...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...